nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A step ahead in Philadelphia chromosome-positive acute lymphoblastic leukaemia
|
Ribera, Josep-Maria |
|
2018 |
5 |
12 |
p. e602-e603 |
artikel |
2 |
Bortezomib, lenalidomide, and dexamethasone with panobinostat for front-line treatment of patients with multiple myeloma who are eligible for transplantation: a phase 1 trial
|
Manasanch, Elisabet E |
|
2018 |
5 |
12 |
p. e628-e640 |
artikel |
3 |
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study
|
Jabbour, Elias |
|
2018 |
5 |
12 |
p. e618-e627 |
artikel |
4 |
Correction to Lancet Haematol 2018; 5: e422–29
|
|
|
2018 |
5 |
12 |
p. e608 |
artikel |
5 |
Correction to Lancet Haematol 2017; 4: e431–42
|
|
|
2018 |
5 |
12 |
p. e608 |
artikel |
6 |
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study
|
Dunleavy, Kieron |
|
2018 |
5 |
12 |
p. e609-e617 |
artikel |
7 |
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial
|
Biondi, Andrea |
|
2018 |
5 |
12 |
p. e641-e652 |
artikel |
8 |
Intensive immunochemotherapy for high-risk aggressive B-cell lymphomas: MYC-rearrangements and beyond
|
Hsi, Eric D |
|
2018 |
5 |
12 |
p. e600-e601 |
artikel |
9 |
The forgotten class of drugs for multiple myeloma: HDAC inhibitors
|
Biran, Noa |
|
2018 |
5 |
12 |
p. e604-e605 |
artikel |
10 |
The humanitarian cost of Yemen's crumbling health system
|
The Lancet Haematology, |
|
2018 |
5 |
12 |
p. e599 |
artikel |
11 |
Tyrosine kinase inhibitor therapy or transplant in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia: striking the balance
|
Ottmann, Oliver |
|
2018 |
5 |
12 |
p. e606-e607 |
artikel |